SCHEMBL437505

SCHEMBL437505

COCc1nnc(C2CCC(C(=O)O)CC2)o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 4/20 0.35
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HTT P42858 3/20 0.33
TP53 P04637 3/20 0.33
ALOX15 P16050 3/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 2/20 0.33
ADCY1 Q08828 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.32
CYP2C19 P33261 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL408238 1.00 PKM (0.39) PKML3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL408783 0.83 PKM (0.40) PKML3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL441093 0.83 PKM (0.40) PKML3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL440519 0.82 PLG (0.35) PKML3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL441266 0.81 HTT (0.37) PKML3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL408745 0.81 HTT (0.37) PKML3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL315752 0.81 PKM (0.42) PKML3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL408399 0.80 CCR5 (0.46) PKML3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL438307 0.80 CCR5 (0.46) PKML3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL408394 0.79 NPC1 (0.42) KMT2AMAPTKDM4ELMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120065196-A1 AMIDE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-15 US disclosed
US-20120065196-A1 AMIDE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-15 US disclosed
WO-2008011130-A2 AMIDE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 WO disclosed
WO-2008011130-A2 AMIDE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065196-A1 AMIDE COMPOUNDS DGAT2, DGAT1, DLAT PKM 1657/4885L3MBTL1 1197/4885ALDH1A1 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.